Cargando…
Phase I study of docetaxel in combination with cyclophosphamide as first-line chemotherapy for metastatic breast cancer
This phase I was study conducted to establish the maximum tolerated dose, dose-limiting toxicity, and recommended dose of docetaxel in combination with cyclophosphamide as first-line chemotherapy for metastatic breast cancer. Twenty-six patients were treated with cyclophosphamide (600 mg m(−2), intr...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2002
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376193/ https://www.ncbi.nlm.nih.gov/pubmed/12402144 http://dx.doi.org/10.1038/sj.bjc.6600626 |